期刊文献+

硫酸镁联用硝苯地平治疗妊娠期高血压的疗效观察 被引量:1

原文传递
导出
摘要 目的探讨硫酸镁联用硝苯地平治疗妊娠期高血压的效果及凝血指标变化。方法选取本院2016年5月~2018年1月100例妊娠期高血压患者,随机分为观察组及对照组,每组50例。对照组患者给予硫酸镁治疗,观察组在对照组的基础上联用硝苯地平。比较两组患者血压水平、凝血功能指标变化以及妊娠不良结局发生情况。结果观察组临床治疗有效率(92.00%)高于对照组(76.00%),差异有统计学意义(P<0.05);两组患者治疗后收缩压和舒张压均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05);两组患者治疗后血浆凝血酶原时间(PT)、血浆凝血酶时间(TT)、活化部分凝血活酶原时间(APIT)水平较治疗前升高,且观察组高于对照组;两组患者纤维蛋白原(FIB)水平较治疗前下降,且观察组低于对照组,差异有统计学意义(P<0.05);观察组患者不良妊娠结局发生率(10.00%)低于对照组(28.00%),差异有统计学意义(P<0.05)o结论硫酸镁联用硝苯地平治疗妊娠期高血压疗效好,可降低患者血压水平,改善凝血功能,减少不良妊娠结局的发生。
作者 陈井丽
出处 《医学新知》 CAS 2018年第6期665-667,共3页 New Medicine
  • 相关文献

二级参考文献64

  • 1Li Wang,Zhi-Qiang Liu,Ying-Qian Huo,Li-Juan Yao,Xue-Gong Wei,Yun-Fang Wang.Change of hs-CRP,sVCAM-1,NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifudipine[J].Asian Pacific Journal of Tropical Medicine,2013,6(11):897-901. 被引量:46
  • 2王九丽,秦小娟.硫酸镁及硫酸镁联合硝苯地平治疗妊高症84例疗效比较[J].航空航天医药,2011,22(1):89-90. 被引量:134
  • 3宫继勇,田万林.妊娠期高血压疾病患者凝血功能及血栓前状态各指标的临床意义[J].蚌埠医学院学报,2006,31(1):80-82. 被引量:6
  • 4邱东飚,郑鹏凌,张彬.妊娠高血压综合征患者凝血功能的变化[J].中华高血压杂志,2007,15(6):509-510. 被引量:11
  • 5Giuseppe Mancia,Robert Fagard,Krzysztof Narkiewicz,Josep Redon,Alberto Zanchetti,Michael B?,hm,Thierry Christiaens,Renata Cifkova,Guy De Backer,Anna Dominiczak,Maurizio Galderisi,Diederick E. Grobbee,Tiny Jaarsma,Paulus Kirchhof,Sverre E. Kjeldsen,Sté,phane Laurent,Athanasios J. Manolis,Peter M. Nilsson,Luis Miguel Ruilope,Roland E. Schmieder,Per Anton Sirnes,Peter Sleight,Margus Viigimaa,Bernard Waeber,Faiez Zannad.??2013 ESH/ESC Guidelines for the management of arterial hypertension(J)Blood Pressure . 2013 (4)
  • 6Shashank Shekhar,Chanderdeep Sharma,Sita Thakur,Suresh Verma.??Oral Nifedipine or Intravenous Labetalol for Hypertensive Emergency in Pregnancy: A Randomized Controlled Trial(J)Obstetrics & Gynecology . 2013 (5)
  • 7Sarah C. Campbell,Chris Stockmann,Alfred Balch,Erin A. S. Clark,Manijeh Kamyar,Michael Varner,E. Kent Korgenski,Joshua L. Bonkowsky,Michael G. Spigarelli,Catherine M. T. Sherwin.??Intrapartum Magnesium Sulfate and the Potential for Cardiopulmonary Drug–Drug Interactions(J)Therapeutic Drug Monitoring . 2014 (4)
  • 8Mahaneem Mohamed,Ernest T. Larmie,Harbindar J. Singh,Mohd. S. Othman.??Tissue kallikrein and kininogen levels in fetoplacental tissues from normotensive pregnant women and women with pregnancy-induced hypertension(J)European Journal of Obstetrics and Gynecology . 2006 (1)
  • 9Wang, I-Kuan,Muo, Chih-Hsin,Chang, Yi-Chih,Liang, Chih-Chia,Chang, Chiz-Tzung,Lin, Shih-Yi,Yen, Tzung-Hai,Chuang, Feng-Rong,Chen, Pei-Chun,Huang, Chiu-Ching,Wen, Chi-Pang,Sung, Fung-Chang,Morisky, Donald E.??Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study(J)Canadian Medical Association. Journal . 2013 (3)
  • 10S. Al-Nasiry,L. Vercruysse,M. Hanssens,C. Luyten,R. Pijnenborg.??Interstitial Trophoblastic Cell Fusion and E-cadherin Immunostaining in the Placental Bed of Normal and Hypertensive Pregnancies(J)Placenta . 2009 (8)

共引文献428

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部